Optimizing Biomarker Testing in Your Practice: Leveraging In-House Testing Strategies - Episode 8

Enhancing Multidisciplinary Coordination and Treatment Planning Through In-House Testing

,

Panelists discuss how in-house testing facilities significantly enhance multidisciplinary coordination by enabling rapid result turnaround and real-time treatment adjustments. This streamlined process facilitates immediate care planning among specialists, leading to faster clinical decisions and reduced wait times. Studies demonstrate that on-site testing correlates with improved patient outcomes through earlier interventions, decreased length of stay, and enhanced treatment monitoring, ultimately supporting more efficient and responsive patient care delivery.

EP. 1: Key Considerations When Ordering Biomarker Testing
EP. 2: The Importance of Broad Biomarker Testing: Uncovering Actionable Targets Across Tumor Types
EP. 3: When to Choose Narrow Panel Testing Over Comprehensive Testing in Biomarker Analysis
EP. 4: Centralized vs Decentralized Biomarker Testing: Workflow, Control, and Collaboration Insights
EP. 5: In-House Comprehensive Genomic Profiling: Expert Insight Into Balancing Benefits and Challenges
EP. 6: Implementing In-House Biomarker Testing: Rationale and Key Considerations
EP. 7: Optimizing In-House Testing: Enhancing Efficiency for Timely Results and Treatment Decisions
Now Viewing
EP. 8: Enhancing Multidisciplinary Coordination and Treatment Planning Through In-House Testing
EP. 9: Impact of In-House Testing on Improved Cancer Care: Timely Decisions and Enhanced Treatment Accuracy

Video series above is prompted by the following:

  • How has in-house testing impacted multidisciplinary coordination and treatment planning at your institution?
  • Discuss the impact of in-house testing on patient outcomes and overall quality of care.